# US 2021/0341485 A1 · Exosome Detection in Microfluidic Droplets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0341485 A1
- Document ID: US20210341485A1
- Status: Published application
- Kind: A1
- Application number: 17/266,671
- Filed: 2019-08-08
- Published: 2021-11-04
- Earliest claimed: 2018-08-08
- Assignees: Northeastern University
- Applicants: Northeastern University
- Inventors: Saheli SARKAR; Tania KONRY
- Web page: https://patentgrep.com/patent/US20210341485A1

## CPC

- G01N 33/57585: {involving compounds identifiable in body fluids}
- C12Q 1/6844: Nucleic acid amplification reactions
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 21/6458: {Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16)}
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N 2458/10: Oligonucleotides as tagging agents for labelling antibodies
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A platform technology for the detection and quantification of biomarkers in exosomes secreted by single cells uses a microfluidic system and provides methods of diagnosis and prognosis of cancer and other conditions using the biomarkers. Single cells can be obtained from a subject and characterized by their exosome population. The biomarkers can be detected at extremely low levels using rolling circle amplification and multiplex analysis to enhance specificity and sensitivity of the analysis.

## Claims

### Claim 1

A method of detecting and/or quantifying a biomarker secreted from single cells, the method comprising the steps of:
(a) providing a microfluidic system configured to encapsulate single cells and one or more reagents into microfluidic aqueous droplets in oil, and to perform fluorescence imaging microscopy of the droplets;
(b) encapsulating single cells combined with one or more detection reagents for said biomarker in microfluidic droplets of the system provided in (a); and
(c) detecting and/or quantifying the biomarker in extracellular spaces of the microfluidic droplets.

### Claim 2 (depends on 1)

The method of claim 1, wherein the biomarker is associated with an exosome, and the exosome is detected or quantified.

### Claim 3 (depends on 1)

The method of claim 1, wherein step (c) comprises performing a rolling circle amplification (RCA) reaction in the microfluidic droplets.

### Claim 4 (depends on 1)

The method of claim 1, wherein the biomarker is a nucleic acid or a protein.

### Claim 5 (depends on 3)

The method of claim 3, wherein the biomarker is a nucleic acid and the RCA reaction amplifies the nucleic acid.

### Claim 6 (depends on 3)

The method of claim 3, wherein the biomarker is a protein, wherein one of the one or more reagents is a binding agent that specifically binds to the protein, and wherein the binding agent is linked to a nucleic acid tag or bar code which is amplified in the RCA reaction.

### Claim 7 (depends on 1)

The method of claim 1, wherein the biomarker is selected from the group consisting of CD63, CD9, CD81, ALIX, perforin, FasL and EGFR.

### Claim 8 (depends on 1)

The method of claim 1, wherein two or more biomarkers are detected and/or quantified.

### Claim 9 (depends on 1)

The method of claim 1, wherein the cells are obtained from a subject.

### Claim 10 (depends on 9)

The method of claim 9, wherein the subject is a human or other mammal.

### Claim 11 (depends on 9)

The method of claim 9, wherein the method is performed to aid in diagnosis or prognosis of a medical condition of the subject.

### Claim 12 (depends on 11)

The method of claim 11, wherein the medical condition is cancer.

### Claim 13

A kit comprising (i) a microfluidic device configured to encapsulate single cells and one or more reagents into microfluidic aqueous droplets in oil, (ii) one or more reagents capable of detecting and/or quantifying a biomarker secreted from a cell, and optionally (iii) one or more reagents for performing an RCA reaction.

### Claim 14 (depends on 13)

The kit of claim 13, wherein the biomarker is associated with an exosome.

### Claim 15 (depends on 13)

The kit of claim 13, wherein the kit comprises reagents for the detection and/or quantification of two or more biomarkers secreted from a cell.
